Cephalalgia

Papers
(The H4-Index of Cephalalgia is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll111
Genetic characterization of the endocannabinoid system and psychiatric features in patients with migraine and medication overuse headache90
Evidence-based guidelines for the pharmacological treatment of migraine88
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world82
Harassment in the headache field: a global web-based cross-sectional survey69
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials66
International Classification of Headache Disorders-4 – Work in Progress 165
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care55
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria50
Call for papers48
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system45
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study44
Diagnosis of idiopathic intracranial hypertension - the importance of excluding secondary causes: A systematic review40
Effect of Altmetric score on manuscript citations: A randomized-controlled trial40
An altered reward system characterizes chronic migraine with medication overuse headache36
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury35
Systemic lupus erythematosus mimicking retinal migraine: a case report35
Depression screening in migraine - A double-edged sword34
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study32
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies32
Painful nervus intermedius neuropathy attributed to Bell's palsy: The need for independent diagnostic criteria31
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex31
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”31
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization30
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment30
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition29
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa29
COVID-19 vaccination-triggered cluster headache episodes with frequent attacks29
Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions29
0.061589002609253